Gavin MacBeath
Vorstandsvorsitzender bei TSCAN THERAPEUTICS, INC.
Vermögen: 362 801 $ am 30.04.2024
Aktive Positionen von Gavin MacBeath
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TSCAN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 24.05.2023 | - |
| Vorstandsvorsitzender | 28.03.2023 | - | |
| Geschäftsführer | 01.06.2022 | 24.05.2023 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.12.2018 | 24.05.2023 | |
| Finanzdirektor/CFO | 21.07.2023 | 29.01.2024 |
Karriereverlauf von Gavin MacBeath
Ehemalige bekannte Positionen von Gavin MacBeath
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ABPRO CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2017 | 01.07.2018 |
| MERRIMACK PHARMACEUTICALS, INC. | Gründer | 01.01.1993 | 01.09.2017 |
| Corporate Officer/Principal | 13.07.2011 | 01.09.2017 | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.07.2002 | 01.06.2010 |
Ausbildung von Gavin MacBeath
| University of Manitoba | Undergraduate Degree |
| The Scripps Research Institute | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
- Börse
- Insiders
- Gavin MacBeath
- Erfahrung
